卡培他滨“氟尿嘧啶”-capecitabine,"fluorouracil"
注释ID
1184471949
变量_单倍型
rs75017182
基因
DPYD
药物名称(英)
capecitabine,"fluorouracil"
药物名称(中)
卡培他滨“氟尿嘧啶”
PMID
24167597
类型
Dosage
含义
yes
记事
Clinical data about adverse events were collected from patient records and laboratory charts for 12 weeks after the initiation of therapy. Delays or reductions in the administration of 5'FU or capecitabine due to adverse events were recorded as primary outcomes, and grade 3,4,5 adverse events were analyzed as secondary outcomes. "Dose" here refers to dose modification. Note: the reported parameters for this SNP are really for a haplotype (the authors refer to it as a "signature") that includes any minor alleles for the following SNPs: rs3918290 (T), rs67376798 (A), rs75017182(C), rs56038477 (T).
专家论述
Genotype CG is associated with dose of capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to genotype GG.
等位基因
CG
专家评论
备注
变体注释摘要
id研究类型特征类型
26071 cohort Study Cohort
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3